Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1981 2
1982 3
1983 3
1984 6
1985 2
1986 3
1987 5
1988 3
1989 8
1990 12
1991 7
1992 10
1993 6
1994 14
1995 14
1996 10
1997 13
1998 17
1999 24
2000 24
2001 43
2002 48
2003 54
2004 64
2005 86
2006 98
2007 119
2008 127
2009 148
2010 149
2011 138
2012 186
2013 199
2014 299
2015 328
2016 321
2017 379
2018 383
2019 415
2020 524
2021 609
2022 720
2023 771
2024 806
2025 707
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,132 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial.
Fang W, Li X, Wang Q, Meng X, Zheng W, Sun L, Yao W, Zhuang W, Fan Y, Zhuo M, Luo Y, Zhang Z, Song X, Yang R, Yang J, Jin X, Diao Y, Ge J, Zhang L. Fang W, et al. Among authors: yao w. BMJ. 2025 Jun 5;389:e085680. doi: 10.1136/bmj-2025-085680. BMJ. 2025. PMID: 40473437 Free PMC article. Clinical Trial.
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.
Barlesi F, Yao W, Duruisseaux M, Doucet L, Martínez AA, Gregorc V, Juan-Vidal O, Lu S, De Bondt C, de Marinis F, Linardou H, Kim YC, Jotte R, Felip E, Lo Russo G, Reck M, Michenzie MF, Yang W, Meade JN, Korytowsky B, Mok TSK; KRYSTAL-12 Investigators. Barlesi F, et al. Among authors: yao w. Lancet. 2025 Aug 9;406(10503):615-626. doi: 10.1016/S0140-6736(25)00866-9. Lancet. 2025. PMID: 40783289 Clinical Trial.
Free-space high-Q nanophotonics.
Yu J, Yao W, Qiu M, Li Q. Yu J, et al. Among authors: yao w. Light Sci Appl. 2025 Apr 27;14(1):174. doi: 10.1038/s41377-025-01825-x. Light Sci Appl. 2025. PMID: 40289110 Free PMC article. Review.
Translation dysregulation in cancer as a source for targetable antigens.
Weller C, Bartok O, McGinnis CS, Palashati H, Chang TG, Malko D, Shmueli MD, Nagao A, Hayoun D, Murayama A, Sakaguchi Y, Poulis P, Khatib A, Erlanger Avigdor B, Gordon S, Cohen Shvefel S, Zemanek MJ, Nielsen MM, Boura-Halfon S, Sagie S, Gumpert N, Yang W, Alexeev D, Kyriakidou P, Yao W, Zerbib M, Greenberg P, Benedek G, Litchfield K, Petrovich-Kopitman E, Nagler A, Oren R, Ben-Dor S, Levin Y, Pilpel Y, Rodnina M, Cox J, Merbl Y, Satpathy AT, Carmi Y, Erhard F, Suzuki T, Buskirk AR, Olweus J, Ruppin E, Schlosser A, Samuels Y. Weller C, et al. Among authors: yao w. Cancer Cell. 2025 May 12;43(5):823-840.e18. doi: 10.1016/j.ccell.2025.03.003. Epub 2025 Mar 27. Cancer Cell. 2025. PMID: 40154482 Free article.
METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy.
Wang C, Shen S, Kang J, Sugai-Munson A, Xiao X, Zhang Y, Zhu J, Liu Z, McKay TB, Akeju O, Jonas ER, Ambardekar AV, Bristow MR, Yao W, Li H. Wang C, et al. Among authors: yao w. Circulation. 2025 Aug 5;152(5):327-345. doi: 10.1161/CIRCULATIONAHA.124.070279. Epub 2025 May 13. Circulation. 2025. PMID: 40357551
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.
Shi L, Zhang Z, Mei S, Wang Z, Xu Z, Yao W, Liu L, Yuan M, Pan Y, Zhu K, Liu K, Meng F, Sun J, Liu W, Xie X, Dong T, Huang L, Meng F, Fu JL, Li Y, Zhang C, Fan X, Shi M, Zhang Y, Li Y, Xie WF, Zhang P, Wang FS. Shi L, et al. Among authors: yao w. Signal Transduct Target Ther. 2025 Jul 29;10(1):238. doi: 10.1038/s41392-025-02318-4. Signal Transduct Target Ther. 2025. PMID: 40721581 Free PMC article. Clinical Trial.
7,132 results